Key Takeaways
An anemia chart is a diagnostic reference tool that classifies anemia into microcytic, normocytic, and macrocytic categories based on MCV, RDW, and hemoglobin levels.
WHO defines anemia as hemoglobin <13 g/dL in adult males and <12 g/dL in non-pregnant adult females; normal RDW ranges from 11.5% to 14.5%.
Key differentiators include serum ferritin, TIBC, reticulocyte count, and peripheral blood smear findings that help distinguish iron deficiency from B12/folate deficiency and chronic disease anemia.
Practice management software like Pabau captures anemia workup findings — MCV category, hemoglobin severity, and next-step tests — in organized patient records.
Severity can be graded on WHO’s three-tier scale (mild, moderate, severe) for general practice, or CTCAE’s four-point scale for oncology settings — matching the system to your setting avoids miscommunication.
Download your free anemia chart
Anemia Chart
A comprehensive diagnostic reference covering morphologic classification (microcytic, normocytic, macrocytic), hemoglobin severity thresholds, lab value interpretation (MCV, RDW, ferritin, TIBC, reticulocyte count), WHO diagnostic criteria, and stepwise differential diagnosis pathways for clinical practice.
Download templateWhat is an anemia chart?
An anemia chart is a clinician-ready reference tool for classifying, evaluating, and tracking patients with suspected or confirmed anemia. It pulls the classification of anemia by morphology (microcytic, normocytic, macrocytic), WHO hemoglobin severity thresholds, and the key lab markers — MCV, RDW, serum ferritin, TIBC, reticulocyte count, and peripheral smear findings — into a single visual guide.
A practice-focused chart connects each lab result to the next clinical decision, so you can reach a differential diagnosis and prioritize the workup in seconds instead of flipping between references.
Anemia affects an estimated 9.3% of the US population ages 2 and older, and is more common in females (13.0%) than males (5.5%), according to CDC NCHS data from August 2021 to August 2023. A chart that ties hemoglobin levels to severity grading and clinical features gives you that read at a glance and supports consistent biomarker interpretation.
The chart serves three immediate purposes: first, it confirms WHO diagnostic thresholds for anemia (hemoglobin <13 g/dL in adult males, <12 g/dL in non-pregnant females); second, it maps morphologic findings (low MCV, normal MCV, high MCV) to probable etiologies; and third, it guides next-step testing based on reticulocyte count and iron metabolism markers.
How to use the chart
A well-designed anemia diagnosis chart follows a stepwise diagnostic logic that mirrors real practice workflows. The five-step pathway below guides practitioners from initial presentation through differential diagnosis confirmation.
- Step 1: Measure hemoglobin and MCV — Start with a complete blood count (CBC) with differential. Record the hemoglobin level and mean corpuscular volume (MCV). Cross-reference the hemoglobin against WHO thresholds printed on the chart to confirm anemia status and severity grade (mild, moderate, severe).
- Step 2: Classify by MCV category — Plot the MCV result into the appropriate morphologic category: microcytic (MCV <80 fL), normocytic (MCV 80-100 fL), or macrocytic (MCV >100 fL). The chart should display differential diagnoses for each category to narrow the field immediately.
- Step 3: Check reticulocyte count and RDW — The reticulocyte count indicates bone marrow response to anemia. Elevated reticulocytes suggest hemolysis or acute bleeding; low reticulocytes point to production defects (iron, B12, folate) or chronic disease. RDW (normal 11.5-14.5%) helps detect mixed causes — elevated RDW alongside normal MCV may suggest early iron deficiency or mixed iron/B12 deficiency.
- Step 4: Measure iron metabolism markers — For microcytic anemia, obtain serum ferritin, TIBC (total iron-binding capacity), and serum iron to assess iron stores. Low ferritin (<15 ng/mL) with elevated TIBC confirms iron deficiency; normal ferritin in a microcytic patient suggests thalassemia trait or chronic disease. This step differentiates iron deficiency from anemia of chronic disease (AOCD), which presents with low iron but low TIBC and preserved or elevated ferritin.
- Step 5: Order targeted tests and document findings — Use clinical documentation best practices to record all findings in the patient record. For suspected B12/folate deficiency, order serum B12 and folate levels; for hemolytic anemia, obtain haptoglobin and LDH; for AOCD, measure EPO levels. Link each result to the morphologic category and next-step treatment decision on the chart.
An effective anemia chart consolidates these five steps into a single reference — eliminating back-and-forth flipping through multiple resources and reducing the risk of missed differential diagnoses.
See how Pabau organizes clinical workflows
Discover how practitioners use Pabau's structured forms and clinical documentation to capture comprehensive anemia workup findings, enabling faster diagnosis and better patient outcomes.
Who benefits most?
An anemia chart is essential for any healthcare setting where practitioners evaluate patients with suspected blood disorders or chronic conditions that commonly present with anemia.
- Primary care physicians and general practitioners who screen for anemia as part of routine wellness exams or when patients present with fatigue, pallor, or dyspnea. Private GPs rely on quick diagnostic references to decide whether to manage anemia in-office or refer to hematology.
- Nurse practitioners and physician assistants in independent or collaborative practice who conduct initial patient evaluations and require evidence-based triage tools to support clinical decision-making and improving patient understanding and compliance with recommended testing.
- Functional and integrative medicine practitioners who assess micronutrient status and anemia risk in wellness-focused populations. Many functional practices use anemia charts to connect subclinical iron or B12 findings to symptom resolution.
- Hematology-focused practices and medical spas that incorporate blood work interpretation into pre-treatment assessment protocols for IV therapy, regenerative medicine, or longevity programs. An organized anemia chart ensures all practitioners apply consistent diagnostic criteria.
- Medical directors and nurse supervisors in multi-location or franchised practices who standardize diagnostic protocols across teams. Distributing a shared anemia chart ensures every practitioner uses the same threshold definitions and differential diagnosis logic.
Benefits for your practice
A structured anemia chart delivers measurable operational and clinical benefits:
- Diagnostic accuracy — Consolidating MCV, RDW, ferritin, TIBC, and reticulocyte interpretation into one visual reference reduces cognitive load and the risk of misclassification. Practitioners apply the same logic every time, reducing variability across the practice.
- Faster workup decisions — Instead of consulting multiple resources, clinicians reference a single chart to determine next-step testing (B12 level, peripheral smear, Coombs test) and narrow differential diagnoses within minutes. This accelerates patient triage and enables quicker treatment initiation.
- Compliance with WHO standards — The chart embeds WHO hemoglobin thresholds and severity grading, ensuring all practitioners follow internationally recognized diagnostic criteria. This is essential for multi-location practices and facilities subject to audit or accreditation review.
- Teaching and training tool — New clinical staff and rotating practitioners reference the chart to understand your practice’s diagnostic approach. It standardizes knowledge transfer and reduces onboarding time for team members unfamiliar with anemia workup protocols.
- Documentation support — When combined with digital intake forms and assessments, an anemia chart becomes part of a HIPAA-compliant clinical documentation system. Lab results, clinical interpretation, and treatment decisions are captured and linked to patient records systematically.
Pro Tip
Flag patients with elevated RDW (>14.5%) alongside normal MCV for follow-up: mixed causes of anemia (e.g., early iron deficiency plus B12 deficiency) may present with normocytic indices but abnormal RDW. Repeat testing in 4-6 weeks if the initial workup is inconclusive.
Anemia classification chart by morphology and severity
The morphologic approach to anemia — classifying cases as microcytic, normocytic, or macrocytic based on MCV — remains the gold standard for differential diagnosis. As an anemia type chart, it maps each category to a distinct set of etiologies; as an anemia investigation chart, it also flags the next-step tests that narrow the differential fastest.
Microcytic anemia chart: causes and key markers
Microcytic anemia (MCV <80 fL) most often points to iron deficiency, thalassemia trait, or anemia of chronic disease (AOCD). Low ferritin confirms iron deficiency, and elevated TIBC supports it; normal-to-high ferritin with low TIBC instead suggests AOCD or chronic inflammation. Key lab markers: serum ferritin, TIBC, serum iron, and a peripheral smear for target cells. Many practices keep this section open as a standalone iron deficiency anemia chart, since low-ferritin, microcytic presentations account for the majority of anemia referrals.
Normocytic anemia chart: causes and key markers
Normocytic anemia (MCV 80-100 fL) covers a wider range — from acute blood loss and hemolytic anemia to bone marrow disorders and renal disease. Check the reticulocyte count: elevated values suggest hemolysis or acute bleeding, while low values point to bone marrow failure or renal insufficiency. Follow-up tests: haptoglobin, LDH, Coombs test, renal function (creatinine, BUN), and EPO level.
Macrocytic anemia chart: causes and key markers
Macrocytic anemia (MCV >100 fL) is most commonly caused by vitamin B12 or folate deficiency (megaloblastic) or alcohol-related bone marrow suppression (non-megaloblastic). Order serum B12 and folate levels; if both are low, investigate the underlying cause — pernicious anemia, dietary insufficiency, or malabsorption. A peripheral smear showing hypersegmented neutrophils confirms megaloblastic anemia.
WHO severity grading overlays hemoglobin thresholds onto this morphologic framework:
- Mild (hemoglobin 11.0-11.9 g/dL in non-pregnant females, 11.0-12.9 g/dL in males) may be managed with outpatient workup and supplementation.
- Moderate (8.0-10.9 g/dL) warrants closer investigation.
- Severe (below 8.0 g/dL) requires prompt intervention, likely referral or hospitalization, and transfusion if the patient is symptomatic.
An integrated anemia chart shows all three dimensions — morphology, severity, and etiology — in one reference.
Lab values and interpretation reference
The anemia chart lab values below cover the constellation of laboratory markers used in a routine anemia workup. Understanding normal ranges and clinical significance prevents misinterpretation and guides targeted follow-up.
| Lab Marker | Normal Range | Clinical Significance in Anemia |
|---|---|---|
| Hemoglobin (Hgb) | Adult M: 13-16 g/dL; Adult F: 12-15 g/dL | Primary diagnostic criterion; values below WHO thresholds confirm anemia presence and severity grade. |
| Mean Corpuscular Volume (MCV) | 80-100 fL | Classifies anemia morphologically; directs differential diagnosis pathway (microcytic, normocytic, macrocytic). |
| Red Cell Distribution Width (RDW) | 11.5-14.5% | Measures RBC size variation; elevated RDW suggests mixed causes or early deficiency; helps differentiate iron deficiency from thalassemia. |
| Reticulocyte Count | 0.5-2% | Indicates bone marrow response; elevated suggests hemolysis or acute bleeding; low suggests production defect (iron, B12, folate, bone marrow disorder). |
| Serum Ferritin | 12-150 ng/mL (F); 24-300 ng/mL (M) | Reflects iron stores; low (<15 ng/mL) confirms iron deficiency; elevated may indicate chronic disease or hemochromatosis. |
| Total Iron-Binding Capacity (TIBC) | 250-425 mcg/dL | Measures transferrin availability; elevated TIBC with low ferritin confirms iron deficiency; low TIBC with normal-to-high ferritin suggests AOCD. |
| Serum B12 | 200-900 pg/mL | Confirms B12 deficiency in macrocytic anemia; levels 200-400 may indicate early deficiency requiring methylmalonic acid and homocysteine testing. |
| Serum Folate | >5.4 ng/mL | Assesses folate status; low folate (along with elevated homocysteine) confirms folate deficiency as cause of macrocytic anemia. |
Note: Reference ranges vary slightly between laboratories. Always reference your facility’s specific range when interpreting results. For functional medicine practitioners, optimizing these ranges (e.g., ferritin 30-100 ng/mL for symptom resolution) may extend beyond standard clinical thresholds.
Supporting anemia workup in your practice
Implementing an anemia workup chart in routine practice requires more than printing a reference — it requires integration into practice workflows, staff training, and patient communication protocols.
Distribute the chart to all clinical staff and include it in new-hire orientation. Conduct a brief training session explaining the morphologic classification logic and how to use the chart to guide test ordering and clinical documentation. Make the chart visible in consultation rooms or break rooms so practitioners reference it during patient visits. Link the chart to your WHO guidelines and ARUP’s anemia testing algorithm as authoritative references for your team.
For multi-location teams, keeping the chart alongside your clinical records keeps interpretation consistent across practitioners. Practice management software like Pabau lets clinicians record each anemia workup in structured clinical documentation — MCV category, hemoglobin severity, and next-step tests — tied directly to the patient record. Every result and the reasoning behind it stays in one place, so any clinician picking up the case sees the full picture.

From lab result to treatment decision
An anemia chart turns blood work interpretation into a fast, repeatable process. Consolidating morphologic classification, WHO severity thresholds, key lab markers, and diagnostic pathways into one reference lets clinicians move from lab results to treatment decisions with confidence.
Whether you run a medical spa screening for anemia before IV therapy or a primary care practice managing chronic disease anemia, a well-built chart cuts diagnostic variability and speeds up care. Download the template above and add it to your team’s standard protocols, then see how Pabau keeps every result tied to documented clinical reasoning.
Continue your research
Need a framework for blood work interpretation? Interpreting Biomarkers Without Overpromising provides practical guidance on translating lab results into clinically meaningful patient conversations.
Looking to standardize clinical documentation? Safer Clinical Notes outlines best practices for documenting anemia findings and diagnostic reasoning in patient records.
Want to scale anemia protocols across your team? Paperless Clinical Workflows shows how integrated clinical documentation systems support consistent diagnostic protocols across multiple practitioners and locations.
Frequently asked questions
What is an anemia chart?
An anemia chart is a diagnostic reference tool that classifies anemia by morphology (microcytic, normocytic, macrocytic), hemoglobin severity, and key lab values (MCV, RDW, ferritin, TIBC, reticulocyte count) to guide differential diagnosis and treatment decisions in clinical practice.
What are the 3 types of anemia by MCV?
Microcytic anemia (MCV <80 fL, common causes: iron deficiency, thalassemia), normocytic anemia (MCV 80-100 fL, causes: hemolysis, acute bleeding, renal disease), and macrocytic anemia (MCV >100 fL, causes: B12 or folate deficiency, alcohol-related bone marrow suppression).
What lab values indicate anemia?
Hemoglobin below WHO thresholds (13 g/dL in adult males, 12 g/dL in non-pregnant adult females) confirms anemia. MCV determines morphologic classification; RDW (normal 11.5-14.5%) and reticulocyte count (normal 0.5-2%) help differentiate causes and assess bone marrow response.
How do you differentiate types of anemia on a blood smear?
Microcytic anemia shows small, hypochromic RBCs; target cells suggest thalassemia. Normocytic anemia with spherocytes and elevated bilirubin suggests hemolytic anemia. Macrocytic anemia displays hypersegmented neutrophils (B12 deficiency) or macroovalocytes. Peripheral smear results confirm lab-based classification and narrow differential diagnosis.
What is normal hemoglobin range?
Normal hemoglobin is 13-16 g/dL in adult males and 12-15 g/dL in non-pregnant adult females. WHO defines anemia as hemoglobin below 13 g/dL in males and below 12 g/dL in non-pregnant females — low hemoglobin levels below these cutoffs confirm the diagnosis and set the severity grade. Pediatric and pregnant thresholds differ and should be referenced separately.
How often should anemia be rechecked?
After initial diagnosis and treatment initiation, recheck hemoglobin in 4-6 weeks for iron supplementation, 8-12 weeks for B12 or folate replacement. For chronic disease anemia, monitor every 3 months. Acute bleeding or hemolytic episodes warrant urgent rechecking. Always reference your practice’s protocols and the patient’s clinical response to guide timing.
What are the 4 types of anemia?
By cause, the common types are iron deficiency anemia, vitamin deficiency anemia (B12 or folate), anemia of chronic disease, and aplastic or hemolytic anemia. By red cell size (MCV), the three morphologic categories on an anemia chart are microcytic, normocytic, and macrocytic.
Where can I download an anemia chart PDF?
Download the free anemia chart PDF from the box at the top of this page. It covers morphologic classification, WHO severity thresholds, and lab value interpretation on a single printable reference sheet.
What are the 7 types of anemia?
Beyond the three morphologic categories on this chart, clinicians also describe anemia by cause: iron deficiency, vitamin deficiency (B12 or folate), anemia of chronic disease, aplastic, hemolytic, sideroblastic, and thalassemia-related anemia. This etiological classification of anemia sits alongside the morphologic one — a single case can appear in both, for example iron deficiency anemia is also microcytic.
What are the four stages of anemia?
WHO’s three-tier grading (mild, moderate, severe) is the most common in general practice, but oncology settings often use the CTCAE scale, which grades anemia on a four-point scale: Grade 1 (hemoglobin just below normal down to 10 g/dL), Grade 2 (10 to 8 g/dL), Grade 3 (below 8 g/dL, transfusion indicated), and Grade 4 (life-threatening, requiring urgent intervention). Match the grading system to the clinical context you’re documenting.
What is a borderline anemia number?
A borderline result usually sits just above the WHO cutoff — roughly 12-12.9 g/dL in non-pregnant women or 13-13.9 g/dL in men — before hemoglobin drops into the mild anemia band. These readings are often picked up incidentally and warrant a recheck alongside ferritin and reticulocyte count rather than immediate treatment.